Viewing StudyNCT00322608



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00322608
Status: COMPLETED
Last Update Posted: 2011-01-10
First Post: 2006-05-04

Brief Title: Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma
Sponsor: Nereus Pharmaceuticals Inc
Organization: Nereus Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Cancer
Keywords:
Name View
Lymphomas View
Solid Tumors View